About
Attune Neurosciences, Inc. is a clinical-stage medical device company based in Menlo Park, California, founded in 2019. The company is dedicated to enhancing human health and performance through non-invasive neurotechnology solutions. It specializes in developing a wearable ultrasound device for deep brain therapy, which targets specific brain regions to address neurological and psychiatric conditions. This innovative device modulates treatment with high precision, affecting significantly less tissue compared to traditional drug therapies. Attune's product platform aims to provide effective neuromodulation for various disorders, offering a user-friendly, non-drug alternative. The company is currently in the clinical stage, exploring the potential of its technology across multiple health conditions. Attune Neurosciences is backed by notable investors and collaborators, including leading venture capital firms and government agencies like the National Institutes of Health and DARPA. With a small team and reported revenues under $5 million, the company is positioned as a growing startup focused on innovation in the healthcare industry.
Technologies
Keywords
Company Information
-
Employees 20
-
Founded 2019
-
Total Funding $3750000
Location
San Francisco, California, United States, 94107